|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.47/-2.54
|
企业价值
2.82B
|
资产负债 |
每股账面净值
9.11
|
现金流量 |
现金流量率
0.08
|
损益表 |
收益
110.32M
|
每股收益
0.60
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/30 00:56 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. |